Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mojeed Ayoola Ashiru"'
Autor:
Moriam Dasola Adeoye, Abel Kolawole Oyebamiji, Mojeed Ayoola Ashiru, Rasheed Adewale Adigun, Olabisi Hadijat Olalere, Banjo Semire
Publikováno v:
Eclética Química, Vol 47, Iss 4, Pp 27-36 (2022)
The 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (2HMN) is a powerful antibacterial and antiparasitic drug used alongside other drugs against Helicobacter pylori infection and was investigated the effects of substituents: –OH (A), H (B), –SPh (C)
Externí odkaz:
https://doaj.org/article/dddf25061a2b4e8c9032b7c65ff1eda2
Autor:
Abdul-Quddus Kehinde Oyedele, Nurudeen Abiodun Owolabi, Tope Tunji Odunitan, Abosede Ajibare Christiana, Rukayat Olajumoke Jimoh, Waliu Olatunji Abdul Azeez, Maryam Bello-Hassan Titilayo, Abiola Sarah Soares, Adedayo Toluwani Adekola, Teslim Oluwaseyi Abdulkareem, Samson Olabode Oyelekan, Mojeed Ayoola Ashiru, Ibrahim Olajide Gbadebo, Habeebah Eyinade Olajumoke, Ibrahim Damilare Boyenle, Abdeen Tunde Ogunlana
Publikováno v:
Informatics in Medicine Unlocked, Vol 37, Iss , Pp 101170- (2023)
A prospective target for the therapy of solid tumors is KRAS G12D, the most prevalent oncogenic KRAS mutation. However, despite decades of research that focused on the identification of druggable compounds against this highly challenging therapeutic
Externí odkaz:
https://doaj.org/article/5d49b7965d9e448483893b2f7c5a0d6b
Autor:
Mojeed Ayoola Ashiru, Sherif Olabisi Ogunyemi, Oluwakemi Rita Temionu, Abosede Christina Ajibare, Nsikak Cicerella Cicero-Mfon, Ogechi Augustina Ihekuna, Monsurat Olatoun Jagun, Latifatu Abdulmumin, Quadri Kolawole Adisa, Yemisi Elizabeth Asibor, Chika Joseph Okorie, Mariam Omowumi Lawal, Musa Oladayo Babalola, Ibrahim Tope Abdulrasaq, Latifat Bukola Salau, Idayat Omotolani Olatunji, Memunat Alake Bankole, Abibat Bisola Daud, Ayodeji Oluwadamilare Adeyemi
Publikováno v:
Journal of Molecular Modeling. 29
Autor:
Abdul-Quddus Kehinde, Oyedele, Temitope Isaac, Adelusi, Abdeen Tunde, Ogunlana, Rofiat Oluwabusola, Adeyemi, Opeyemi Emmanuel, Atanda, Musa Oladayo, Babalola, Mojeed Ayoola, Ashiru, Isong Josiah, Ayoola, Ibrahim Damilare, Boyenle
Publikováno v:
Journal of Molecular Modeling. 28
In the vast majority of malignancies, the p53 tumor suppressor pathway is compromised. In some cancer cells, high levels of MDM2 polyubiquitinate p53 and mark it for destruction, thereby leading to a corresponding downregulation of the protein. MDM2